scholarly journals Nationwide screening of Pompe disease in patients with unspecified muscle weakness, hyperCKemia, and respiratory insufficiency: preliminary results

2020 ◽  
Vol 21 (Suppl.B) ◽  
pp. 3-9
Author(s):  
Olesja Parmová ◽  
Lívie Mensová ◽  
Stanislav Voháňka ◽  
Radim Mazanec
2021 ◽  
Author(s):  
Kexin Jiao ◽  
Jihong Dong ◽  
Sushan Luo ◽  
Liqiang Yu ◽  
Qing Ke ◽  
...  

Abstract Backgroud: Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting with the classic infantile form, the others subtypes have a heterogeneous presentation that makes an early and accurate diagnosis difficulty. A multicenter observational study was aimed to assess the prevalence of late-onset Pompe disease (LOPD) in high-risk population, using dried blood spot (DBS) as a main screening tool.Methods: 20 Chinese neuromuscular centers were involved in the early LOPD screening study. Inclusion criteria were: (1) age ≥1 years, (2) either one of a) persistent hyperCKemia; or b) muscle weakness of axial and/or limb-girdle muscles; or c) unexplained restrictive respiratory insufficiency. Enzymatic activity of acid α-glucosidase (GAA) was measured on DBS by tandem mass spectrometry (MS/MS) assay. For the final diagnosis genotype was assessed by next-generation sequencing.Result: In a 9-month period, we studied 492 cases: 26 positive samples (5.3%) were detected by DBS screening. Molecular studies finally confirmed LOPD diagnosis in 8 cases (1.6%). The GAA activities in individuals bearing pseudodeficiency alleles were well separated from those in LOPD patients by MS/MS assay. The median interval from the onset of symptoms to diagnosis was 5 years. Besides axial/proximal muscle weakness, all patients showed respiratory insufficiency with a mean forced vital capacity of predicted of 48%. The level of creatine kinase ranged from normal to no more than 5-fold of upper normal limit. LOPD with isolated hyperCKemia was not identified.Conclusions: This study confirms that DBS test is a reliable method for screening for LOPD. Respiratory insufficiency is earlier and more severe among Chinese LOPD patients. LOPD presented with paucisymptomatic hyperCKemia. Therefore, a prompt diagnosis is critical to prognosis.


2019 ◽  
Vol 29 ◽  
pp. S60
Author(s):  
J. Teodoro ◽  
M. Silva ◽  
L. Zimerman ◽  
K. Turke ◽  
L. Silva ◽  
...  

2016 ◽  
Vol 17 (10) ◽  
pp. 1735 ◽  
Author(s):  
Matthias Boentert ◽  
Hélène Prigent ◽  
Katalin Várdi ◽  
Harrison Jones ◽  
Uwe Mellies ◽  
...  

Author(s):  
Milan Zimmermann ◽  
Natalie Deininger ◽  
Sophia Willikens ◽  
Tobias B. Haack ◽  
Kathrin Grundmann-Hauser ◽  
...  

Abstract Introduction/aims Hereditary transthyretin amyloidosis with polyneuropathy (hATTRPN) is an autosomal dominant multi-organ disorder manifesting in the third to fifth decade with the key clinical features of distal and painful sensory loss of the lower limbs and autonomic dysregulation. Motor neuropathy and cardiomyopathy evolve in the course of the disease. Pompe disease is an autosomal recessive disease leading to decreased levels of lysosomal enzyme acid α-glucosidase and proximal muscle weakness. We report the clinical features and diagnostic workup in the rare case of a patient with ATTR amyloidosis and late-onset Pompe disease, both genetically confirmed. Methods We performed a detailed clinical assessment, exome sequencing, and biochemical measurements. Results The patient presented with a distal, painful hypaesthesia of both legs, a cardiomyopathy, and a muscle weakness in the form of a girdle-type pattern of the arms and legs at the beginning and a spreading to distal muscle groups in the course of disease. Discussion This study highlights the importance of searching for co-occurrence of rare monogenetic neuromuscular diseases, especially in cases in which all clinical features can be readily explained by a single gene defect.


2016 ◽  
Vol 26 (11) ◽  
pp. 796-800 ◽  
Author(s):  
Olcay Ünver ◽  
Nilüfer Eldeş Hacıfazlıoğlu ◽  
Elif Karatoprak ◽  
Ayfer Sakarya Güneş ◽  
Güneş Sağer ◽  
...  

2019 ◽  
Vol 20 (3) ◽  
pp. 751 ◽  
Author(s):  
Angela McCall ◽  
Mai ElMallah

The authors of the recently published, “Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases”, provide an important review of the various mechanisms of lysosomal storage diseases (LSD) and how they culminate in similar clinical pathologies [...]


2009 ◽  
Vol 106 (23) ◽  
pp. 9419-9424 ◽  
Author(s):  
L. R. DeRuisseau ◽  
D. D. Fuller ◽  
K. Qiu ◽  
K. C. DeRuisseau ◽  
W. H. Donnelly ◽  
...  

2015 ◽  
Vol 51 (5) ◽  
pp. 722-730 ◽  
Author(s):  
Jeffrey J. Horvath ◽  
Stephanie L. Austin ◽  
Laura E. Case ◽  
Karla B. Greene ◽  
Harrison N. Jones ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document